Results for "cancer epidemiology"
Kidney Cancer
Kidney cancer, also known as renal cancer, comprises malignant tumors that originate in the kidney’s tissues and can spread to other organs if untreated.
Health & MedicineStomach Cancer
** Stomach cancer (gastric cancer) is a malignant tumor arising from the lining of the stomach, most commonly an adenocarcinoma, that can spread to distant organs and presents with nonspecific gastrointestinal symptoms. **CONTENT:** ## Overview Stomach cancer, also called **gastric cancer**, originates when the cells that line the stomach begin to grow uncontrollably. The majority of cases are **gastric adenocarcinomas**, which develop from the glandular cells that produce mucus and digestive enzymes. Less common histologic types include **gastric lymphomas** (originating from immune tissue) and **mesenchymal tumors** such as gastrointestinal stromal tumors (GISTs). Because early disease often mimics benign conditions like heartburn or gastritis, diagnosis is frequently delayed until the tumor has progressed. Early symptoms may be subtle: persistent **heartburn**, upper abdominal discomfort, nausea, and a reduced appetite. As the tumor enlarges or invades adjacent structures, more alarming signs appear—unexplained **weight loss**, **jaundice** (yellowing of the skin and eyes), **vomiting**, difficulty swallowing (**dysphagia**), and **occult or overt gastrointestinal bleeding** that can manifest as black stools or visible blood. When cancer spreads (metastasizes), the liver, lungs, bones, peritoneum (abdominal lining), and regional **lymph nodes** are common sites. Prompt evaluation of persistent gastrointestinal symptoms is essential; if you experience any of the above, seek medical attention promptly. ## History/Background The first documented descriptions of stomach cancer date back to ancient Egyptian papyri, but systematic study began in the 19th century when pathologists like **Rudolf Virchow** recognized malignant gastric lesions. In the early 20th century, **Theodor Boveri** and later **Helmut H. B.** identified distinct histologic subtypes, laying groundwork for modern classification. The **Lauren classification** (1965) distinguished intestinal‑type and diffuse‑type adenocarcinomas, a system still used clinically. Epidemiologically, stomach cancer was once the leading cause of cancer death worldwide; however, after the mid‑20th century, incidence declined sharply in Western nations, largely due to improved **food preservation**, reduced **Helicobacter pylori** infection rates, and widespread **screening endoscopy** in high‑risk regions such as Japan and South Korea. In 2020, the World Health Organization estimated over 1 million new cases annually, with the highest burden in East Asia, Eastern Europe, and parts of Latin America. ## Key Information - **Etiology:** Chronic **H. pylori** infection, dietary nitrosamines, smoked or salted foods, smoking, heavy alcohol use, and certain genetic syndromes (e.g., hereditary diffuse gastric cancer due to **CDH1** mutations) increase risk. - **Pathology:** Most gastric cancers are **adenocarcinomas**, subdivided into **intestinal‑type** (gland‑forming, linked to chronic gastritis) and **diffuse‑type** (scattered cells, often signet‑ring cells, associated with CDH1). - **Diagnosis:** Upper endoscopy with biopsy is the gold standard. Imaging (CT, PET‑CT) assesses local invasion and distant spread. Staging follows the **TNM** system (Tumor size, Node involvement, Metastasis). - **Treatment:** Early‑stage disease may be cured with **endoscopic mucosal resection** or **surgical gastrectomy** with lymphadenectomy. Advanced disease requires multimodal therapy—**chemotherapy** (e.g., fluoropyrimidine‑platinum regimens), **targeted agents** (trastuzumab for HER2‑positive tumors), and **immunotherapy** (PD‑1 inhibitors) for selected patients. Palliative care focuses on symptom control and quality of life. - **Prognosis:** Five‑year survival varies dramatically by stage—from >70 % for localized tumors to <5 % for metastatic disease. Early detection dramatically improves outcomes, underscoring the importance of screening in high‑risk populations. - **Prevention:** Eradication of **H. pylori**, dietary modifications (increased fruits/vegetables, reduced smoked foods), smoking cessation, and limiting alcohol intake are evidence‑based preventive measures. **When to seek professional care:** Persistent upper abdominal pain, unexplained weight loss, vomiting, difficulty swallowing, or any sign of gastrointestinal bleeding should prompt evaluation by a healthcare provider. Early assessment can lead to diagnosis at a stage when curative treatment is possible. ## Significance Stomach cancer remains a major global health challenge because of its aggressive nature, late presentation, and variable access to early detection tools. In regions with high incidence, national screening programs have reduced mortality, illustrating the power of public‑health interventions. Advances in molecular profiling have opened pathways for **personalized therapy**, offering hope for patients with previously untreatable disease. Moreover, the study of gastric carcinogenesis has illuminated broader principles of inflammation‑driven cancer, influencing research in other malignancies. Reducing the burden of gastric cancer will require continued investment in **H. pylori** eradication programs, dietary education, and equitable access to endoscopic screening and modern oncologic therapies. **INFOBOX:** - Name: Stomach Cancer (Gastric Cancer) - Type: Malignant neoplasm of the stomach - Date: First modern pathological description – 19th century; major classification (Lauren) – 1965 - Location: Stomach (gastric corpus, antrum, cardia) - Known For: Being one of the most common gastrointestinal cancers worldwide and for its strong association with **Helicobacter pylori** infection **TAGS:** gastric cancer, stomach neoplasm, adenocarcinoma, H. pylori, oncology, gastrointestinal disease, cancer epidemiology, cancer prevention